Amino-Terminal Pro–B-Type Natriuretic Peptides and Prognosis in Chronic Heart Failure

作者: Serge Masson , Roberto Latini

DOI: 10.1016/J.AMJCARD.2007.11.024

关键词:

摘要: In patients with chronic heart failure (HF), amino-terminal pro–B-type natriuretic peptide (NT-proBNP) levels are among the strongest independent predictors of hazard, and their measurement is useful for prognostication across entire spectrum HF disease severity. HF, repeated determinations NT-proBNP appear to convey additional prognostic value relevant adverse outcomes, including death or hospitalization. Although “hard targets” values not entirely defined, morbidity mortality in increase markedly an concentration >1,000 ng/L. Confounding factors (such as renal function obesity) should be kept mind when prognostically evaluating using measurements; however, retained these patients. Thus, serial assessment valuable outpatients, and, such, a at each patient visit following changes clinical stability recommended.

参考文章(35)
Eduardo R Perna, Stella M Macin, Juan P Cimbaro Canella, Ariel Szyszko, Valeria Franciosi, Walter Vargas Morales, Augusto P Bayol, Jorge O Kriskovich, Fernanda Medina, Bilda Gonzalez Arjol, Monica Brizuela, Importance of Early Combined N-Terminal Pro–Brain Natriuretic Peptide and Cardiac Troponin T Measurements for Long-term Risk Stratification of Patients With Decompensated Heart Failure Journal of Heart and Lung Transplantation. ,vol. 25, pp. 1230- 1240 ,(2006) , 10.1016/J.HEALUN.2006.08.004
Ryoji Taniguchi, Yukihito Sato, Tasuku Yamada, Muneo Ooba, Hirokazu Higuchi, Akira Matsumori, Takeshi Kimura, Toru Kita, Combined measurements of cardiac troponin T and N-terminal pro-brain natriuretic peptide in patients with heart failure. Japanese Circulation Journal-english Edition. ,vol. 68, pp. 1160- 1164 ,(2004) , 10.1253/CIRCJ.68.1160
Christian Bruch, Markus Rothenburger, Michael Gotzmann, Juergen Sindermann, Hans H. Scheld, Günter Breithardt, Thomas Wichter, Risk stratification in chronic heart failure: independent and incremental prognostic value of echocardiography and brain natriuretic peptide and its N-terminal fragment. Journal of The American Society of Echocardiography. ,vol. 19, pp. 522- 528 ,(2006) , 10.1016/J.ECHO.2005.12.027
Sheng-Jing Dong, Lisa de las Fuentes, Angela L. Brown, Alan D. Waggoner, Gregory A. Ewald, Víctor G. Dávila-Román, N-terminal Pro B-type Natriuretic Peptide Levels: Correlation with Echocardiographically Determined Left Ventricular Diastolic Function in an Ambulatory Cohort Journal of the American Society of Echocardiography. ,vol. 19, pp. 1017- 1025 ,(2006) , 10.1016/J.ECHO.2006.03.012
Richard W. Troughton, A. Mark Richards, BNP for clinical monitoring of heart failure. Heart Failure Clinics. ,vol. 2, pp. 333- 343 ,(2006) , 10.1016/J.HFC.2006.08.006
Franz Hartmann, Milton Packer, Andrew J.S. Coats, Michael B. Fowler, Henry Krum, Paul Mohacsi, Jean L. Rouleau, Michal Tendera, Alain Castaigne, Stefan D. Anker, Ildiko Amann-Zalan, Silke Hoersch, Hugo A. Katus, Prognostic Impact of Plasma N-Terminal Pro–Brain Natriuretic Peptide in Severe Chronic Congestive Heart Failure A Substudy of the Carvedilol Prospective Randomized Cumulative Survival (COPERNICUS) Trial Circulation. ,vol. 110, pp. 1780- 1786 ,(2004) , 10.1161/01.CIR.0000143059.68996.A7
Paulo Bettencourt, Ana Azevedo, Joana Pimenta, Fernando Friões, Susana Ferreira, António Ferreira, N-Terminal–Pro-Brain Natriuretic Peptide Predicts Outcome After Hospital Discharge in Heart Failure Patients Circulation. ,vol. 110, pp. 2168- 2174 ,(2004) , 10.1161/01.CIR.0000144310.04433.BE
Aldo Clerico, Gian Carlo Zucchelli, Alessandro Pilo, Claudio Passino, Michele Emdin, Clinical relevance of biological variation : the lesson of brain natriuretic peptide (BNP) and NT-proBNP assay Clinical Chemistry and Laboratory Medicine. ,vol. 44, pp. 366- 378 ,(2006) , 10.1515/CCLM.2006.063